Lipoprotein metabolism mediates hematopoietic stem cell responses under acute anemic conditions.
Kiyoka SaitoMark van der GardeTerumasa UmemotoNatsumi MiharadaJulia SjöbergValgardur SigurdssonHaruki ShirozuShunsuke KameiVisnja RadulovicMitsuyoshi SuzukiSatoshi NakanoStefan LangJenny HanssonMartin L OlssonTakashi MinamiGunnar Keppler GourasJohan FlygareKenichi MiharadaPublished in: Nature communications (2024)
Hematopoietic stem cells (HSCs) react to various stress conditions. However, it is unclear whether and how HSCs respond to severe anemia. Here, we demonstrate that upon induction of acute anemia, HSCs rapidly proliferate and enhance their erythroid differentiation potential. In severe anemia, lipoprotein profiles largely change and the concentration of ApoE increases. In HSCs, transcription levels of lipid metabolism-related genes, such as very low-density lipoprotein receptor (Vldlr), are upregulated. Stimulation of HSCs with ApoE enhances their erythroid potential, whereas HSCs in Apoe knockout mice do not respond to anemia induction. Vldlr high HSCs show higher erythroid potential, which is enhanced after acute anemia induction. Vldlr high HSCs are epigenetically distinct because of their low chromatin accessibility, and more chromatin regions are closed upon acute anemia induction. Chromatin regions closed upon acute anemia induction are mainly binding sites of Erg. Inhibition of Erg enhanced the erythroid differentiation potential of HSCs. Our findings indicate that lipoprotein metabolism plays an important role in HSC regulation under severe anemic conditions.
Keyphrases
- iron deficiency
- chronic kidney disease
- liver failure
- drug induced
- low density lipoprotein
- stem cells
- respiratory failure
- transcription factor
- gene expression
- aortic dissection
- dna damage
- cognitive decline
- early onset
- genome wide
- high fat diet
- hepatitis b virus
- human health
- hematopoietic stem cell
- bone marrow
- metabolic syndrome
- extracorporeal membrane oxygenation
- dna methylation
- oxidative stress
- mesenchymal stem cells
- type diabetes
- skeletal muscle
- insulin resistance
- intensive care unit